Executive Leadership Team
The Executive Leadership Team (ELT) is responsible for setting and influencing Genomics England’s strategic direction (with the Board); defining, delivering and evaluating Genomics England’s activities: providing leadership, both inside the organisation and externally as ambassadors and thought leaders.
Prior to his appointment at Genomics England, Chris was COO at QuantumBlack, a bespoke machine learning and AI technology company, and a Partner at McKinsey working on technology strategy topics.
He previously worked for the UK Foreign Office (where he led analytical work at the Counter Terrorism Policy Department), and at the BBC (transitioning to digital broadcasting and iPlayer). He has held board roles at the New Entrepreneurs Foundation, Entrepreneur First and Magic Breakfast.
Chris lives in London with his wife Tara and their three children, and loves nothing more than a winter’s day climbing a snowy mountain followed by a nice dinner with a glass of Italian red wine.
Professor Sir Mark Caulfield
Sir Mark engages with NHS scientific teams and the general public to promote, explains and enthuses about the 100,000 Genomes Project, and oversees the Clinical Interpretation Partnership and Access Review Committee. He is also responsible as Head of Profession (Science and Clinical) for helping us attract and retain the best scientific and clinical talent to the Project and ensuring our clinician community can develop professionally and appropriately within the Project.
Our Ethics team is also part of the Chief Scientist’s team, supporting Genomics England in its ethical governance of the Project, working in line with participants’ consent, the Project’s aims and advising on compliance with relevant medical, academic and data legislation, regulation including Research Ethics Committee (REC) approval, professional guidance and good ethical practice. This includes seeking input from patient groups and Project participants. The Ethics team leads on ethical policy issues, and provides the secretariat for the Ethics Advisory Committee and its standing subgroups on Equalities, Consent and Legacy (the future of mainstreamed NHS genomics beyond the Project).
In January 2019, Sir Mark was appointed interim Chief Executive at Genomics England until October, and in June received a knighthood in the 2019 Queen’s Birthday Honours in recognition of his services to the 100,000 Genomes Project.
Chief Operational Officer and Chief Finance Officer
Graham’s career spans over 25 years with management, commercial and leadership experience at senior levels in blue chip multinational companies with a turnover of up to $33bn.
Previous roles have included Finance Director, Vice President, Non-Executive Director and Chartered Accountant and prior to joining Genomics England, he was Global Head of Commercial Finance at AstraZeneca.
Chief Commercial Officer
This includes creating a portfolio of external investments and strategic alliances that advance technology and product strategies, and helping to meet research, development and commercialisation goals.
The Commercial Team is responsible for the administration of revenue and expenses to generate a financial return, working closely with all Genomics England teams and projects to identify and develop business opportunities.
General Counsel and Company Secretary
He is responsible for all legal activity within Genomics England including ensuring that the organisation complies with the law (Data Protection, Freedom of Information, Human Tissues Act) and the Company’s Articles and policies.
He is also responsible for signing off all procurement and contracting work.
Prior to his role at Genomics England, Nick was a partner in three Top 100 law firms: Pinsent Masons, DLA Piper and Bircham Dyson Bell.
Executive Director of Communications & Engagement
Anna’s team is responsible for all internal and external-facing communications, reputation management and engagement strategies at Genomics England. The team works closely with participants and other stakeholders, including the Department of Health and Social Care, the Office for Life Sciences, NHS England, commercial partners and academic communities.
Anna holds a degree from Cambridge University, and began her career in investment banking. She joined Genomics England in 2019, and prior to this she held roles including Global Communications Director at US health giant, Aetna, and Group Marketing and Communications Director at InHealth Group.
Augusto and his team have designed and implemented the clinical interpretation pipelines that return findings to patients, while ensuring that knowledge accumulated through this process is best used to improve patient care and enhance discovery.
Dr Tom Fowler
Deputy Chief Scientist
Head of Science Partnerships
He also supports wider strategic links with UK Department of Health & Social Care and other Government organisations.
Head of Strategy Planning
John joined Genomics England in June 2018. He is responsible for defining the ongoing strategy and priorities for the company, in partnership with the leadership team and Board. He also works with our other stakeholders, such as the Department of Health and Social Care, the Office for Life Sciences, the NHS and others to define and ensure our fit within the wider UK genomics ecosystem.
John has previously worked for HSBC (in both corporate strategy and digital planning), McKinsey & company, and Standard Chartered Bank.
Head of HR
Kathryn leads our people agenda, ensuring we attract and retain the very best people, able to achieve fantastic results for those using our services. Kathryn joined Genomics England in 2016 and leads a team dedicated to making Genomics England a great place to work.
Prior to joining Genomics England, Kathryn worked in senior human resources and organisational development roles in a range of healthcare and digital service providers, and in financial regulation. Kathryn has a keen interest in behavioural science and its application within the workplace and during business change.